AOD-9604 vs Lemon Bottle
A side-by-side research comparison of AOD-9604 and Lemon Bottle across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | AOD-9604 | Lemon Bottle |
|---|---|---|
| Full name | Advanced Obesity Drug Fragment 176-191 (Modified) | Lemon Bottle (Lipolytic Fat-Dissolving Solution) |
| Category | Weight Management | Weight Management |
| Status | Research compound | Cosmetic injectable (not FDA-approved) |
| Mechanism | Mimics the lipolytic domain of growth hormone (hGH 176-191), stimulating fat oxidation and inhibiting de novo lipogenesis through pathways independent of IGF-1 and growth signaling. | Marketed to break down fat cells locally through lipolytic ingredients (often including a bile-salt-like detergent action and riboflavin), causing adipocyte membrane disruption so fat is released and cleared. Localized, not systemic weight loss. |
| Molecular weight | 1815.08 Da | Blend (not a single molecule) |
| Half-life | ~2-3 hours | Local action |
| Bioavailability | ~90% subcutaneous | Local subcutaneous injection |
| Typical dose | 300 mcg | Per treatment area (provider-administered) |
| Frequency | Daily (morning, fasted) | Sessions spaced weeks apart |
| Route | Subcutaneous injection | Subcutaneous injection by a provider |
AOD-9604 reported benefits
- Fat loss without muscle wasting
- No effect on blood sugar
- Cartilage repair properties
- No HGH-related side effects
Lemon Bottle reported benefits
- Localized fat-pocket reduction (cosmetic)
- Body-contouring for small areas
- Non-surgical option
Related comparisons
Research and educational reference only. Not medical advice.